Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

By Rojas Laimito, Katerin | Sepúlveda Sánchez, Juan Manuel | Manso Sánchez, Luis | Pascual, Tomás | Ciruelos Gil, Eva María. Ecancermedicalscience, 2016 . 10:632. , Formato Vancouver: Laimito KR, Gámez Pozo A, Sepúlveda J, Manso L, López Vacas R, Pascual T et al. Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases. Ecancermedicalscience. 2016 Apr 11;10:632.

Place Hold on Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

By Ciruelos Gil, Eva María | Pascual Martínez, Pascual | Arroyo Vozmediano, María Luisa | Blanco Guerrero, Marta | Manso Sánchez, Luis | Parrilla Rubio, Lucía | Muñoz, César | Vega Alonso, Estela | Calderón, Monica Jackelin | Sancho, Blanca | Cortés-Funes Castro, Hernán. The Breast : official journal of the European Society of Mastology, 2014 . 23(3):201-8. , Formato Vancouver: Ciruelos E, Pascual T, Arroyo Vozmediano ML, Blanco M, Manso L, Parrilla L et al. The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer. Breast. 2014 Jun;23(3):201-8.

Place Hold on The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Search for 'an,phr: 432' with limit(s): 'itype:REV'

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.